Pharmacologic AXL inhibition using a selective AXL inhibitor (R428 or SGI-7079) in tumor cells of C57BL/6 mice significantly increased the expression of PD-1 and MHC-I molecules (43). This evidence concerns the gene AXL and neoplasm.